DE69019122T2 - Stabilisierung und Wartung der biologischen Aktivität des Nervenwachstumsfaktor unter Benützung von natürlichen Gangliosiden oder deren Derivaten. - Google Patents

Stabilisierung und Wartung der biologischen Aktivität des Nervenwachstumsfaktor unter Benützung von natürlichen Gangliosiden oder deren Derivaten.

Info

Publication number
DE69019122T2
DE69019122T2 DE69019122T DE69019122T DE69019122T2 DE 69019122 T2 DE69019122 T2 DE 69019122T2 DE 69019122 T DE69019122 T DE 69019122T DE 69019122 T DE69019122 T DE 69019122T DE 69019122 T2 DE69019122 T2 DE 69019122T2
Authority
DE
Germany
Prior art keywords
growth factor
nerve growth
stabilization
derivatives
maintenance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69019122T
Other languages
English (en)
Other versions
DE69019122D1 (de
Inventor
Valle Francesco Della
Aurelio Romeo
Lanfranco Callegaro
Alberta Leon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT04855589A external-priority patent/IT1238347B/it
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of DE69019122D1 publication Critical patent/DE69019122D1/de
Publication of DE69019122T2 publication Critical patent/DE69019122T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69019122T 1989-11-14 1990-11-14 Stabilisierung und Wartung der biologischen Aktivität des Nervenwachstumsfaktor unter Benützung von natürlichen Gangliosiden oder deren Derivaten. Expired - Fee Related DE69019122T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT04855589A IT1238347B (it) 1989-11-14 1989-11-14 Stabilizzazione e mantenimento dell'attivita' biologica del fattore di crescita nervoso mediante gangliosidi naturali o loro derivati.
IN954CA1990 IN172427B (de) 1989-11-14 1990-11-13

Publications (2)

Publication Number Publication Date
DE69019122D1 DE69019122D1 (de) 1995-06-08
DE69019122T2 true DE69019122T2 (de) 1995-10-05

Family

ID=26324373

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019122T Expired - Fee Related DE69019122T2 (de) 1989-11-14 1990-11-14 Stabilisierung und Wartung der biologischen Aktivität des Nervenwachstumsfaktor unter Benützung von natürlichen Gangliosiden oder deren Derivaten.

Country Status (8)

Country Link
EP (1) EP0433113B1 (de)
JP (1) JPH03179000A (de)
CN (1) CN1052868A (de)
AT (1) ATE122056T1 (de)
AU (1) AU629714B2 (de)
CA (1) CA2029965A1 (de)
DE (1) DE69019122T2 (de)
IN (1) IN172427B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
IT1259176B (it) * 1992-10-23 1996-03-11 Fidia Spa Composizioni farmaceutiche comprendenti monosialoganglioside gm1 (o suo derivato) e fattore neuronotrofico ciliare (cntf) atte al trattamento di patologie del sistema nervoso
FR2703682B1 (fr) * 1993-04-06 1995-05-12 Atochem Elf Sa Procédé de préparation de (méth)acrylate(s) d'alkylimidazolidone.
CN1046734C (zh) * 1995-03-24 1999-11-24 中国科学院上海生理研究所 一种含神经节苷脂为主的糖脂类物质的生产方法
CN103083724A (zh) * 2013-01-31 2013-05-08 东华大学 一种负载gm1和ngf双营养因子的神经组织修复支架的制备方法
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
CN108498523B (zh) * 2017-02-24 2023-06-20 上海交通大学 含不饱和脂肪酸链的神经节苷脂衍生物的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1219839B (it) * 1988-02-08 1990-05-24 Fidia Farmaceutici Purificazione,caratterizazione e applicazione di un fattore neuronotrofico derivato da cervello di nammifero
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle

Also Published As

Publication number Publication date
EP0433113A1 (de) 1991-06-19
ATE122056T1 (de) 1995-05-15
AU6662890A (en) 1991-05-23
CA2029965A1 (en) 1991-05-15
IN172427B (de) 1993-07-24
DE69019122D1 (de) 1995-06-08
JPH03179000A (ja) 1991-08-02
AU629714B2 (en) 1992-10-08
CN1052868A (zh) 1991-07-10
EP0433113B1 (de) 1995-05-03

Similar Documents

Publication Publication Date Title
EP0564739A3 (de)
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
KR950004179B1 (en) N-phosphonylmethoxyalkye derivatives of pyrimidine and purine bases and a therapeutical composition therefrom with antiviral activity
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
ATE122056T1 (de) Stabilisierung und wartung der biologischen aktivität des nervenwachstumsfaktor unter benützung von natürlichen gangliosiden oder deren derivaten.
GB8927546D0 (en) Process for the production of biologically active tgf-beta
HUT51861A (en) Fungicides containing as active substance derivatives of amid substituated by phenil group and process for production of the active substance
HU9200857D0 (en) Process for the production of new tiophenecarbonic acid esthers of amino-alcoholes, their quaterner derivatives and of medical preparations containing them as active agents
EP0251369A3 (en) Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
FI880845A0 (fi) bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
HUT50148A (en) Process for production of derivatives of antiflammation furanon and medical compositions containing them
DE69009195D1 (de) Isoxazol-Derivate mit Anti-Serotonin-Aktivität, deren Herstellungsverfahren und diese enthaltende Zusammensetzungen.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
HUT43920A (en) Insecticides comprising new nitrogenous heterocyclic compounds as active substance and process for preparing the active substances
HUT46224A (en) Process for producing pharmaceutical compositions containing prostaglandin e1-derivatives
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
HUT44903A (en) Substances regulating the growth of plants containing as active substance 2,3,6-substituated phenil-imidasole derivatives and process for production of the active substance
HUT51284A (en) Process for production of epipodofillotoxin glucozides substituated by fluor and medical compositions containing them as active substance
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
PT87704A (pt) Process for preparing pharmaceutical compositions for transdermal delivery containing a 1,4-dihydropyride derivative
HUT47020A (en) Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid
HU906355D0 (en) Process for producing aryl-ureas and pharmaceutical preparatives containing these compounds as active substance

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee